Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer

被引:2
|
作者
Shi, Jinpeng [1 ,2 ]
Li, Jiayu [1 ,2 ]
Wang, Haowei [1 ,2 ]
Li, Xuefei [3 ]
Wang, Qi [1 ,2 ]
Zhao, Chao [3 ]
Cheng, Lei [3 ]
Han, Ruoshuang [1 ,2 ]
Chen, Peixin [1 ,2 ]
Guo, Haoyue [1 ,2 ]
Tang, Zhuoran [1 ,2 ]
Zhou, Caicun [1 ,2 ]
Zhang, Zhemin [1 ,2 ,4 ,5 ]
Wu, Fengying [1 ,2 ,4 ,5 ]
机构
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Thorac Canc Inst, Sch Med, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Lung Canc & Immunol, Shanghai, Peoples R China
[4] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Med Oncol, 507 Zheng Min Rd, Shanghai 200433, Peoples R China
[5] Tongji Univ, Thorac Canc Inst, Sch Med, 507 Zheng Min Rd, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
tumor -associated neutrophil; single -cell RNA-sequencing; non -small cell lung cancer; tumor microenvironment; heterogeneity; SUPPRESSOR-CELLS; ONCOSTATIN-M; T-CELLS; METASTASIS; EXPRESSION; PROMOTES; INVASION; POLARIZATION; RECRUITMENT; RESPONSES;
D O I
10.2147/LCTT.S430967
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Neutrophils act as a non-negligible regulator in the initiation and progression of malignancies, playing bifacial roles in the process. Thus, to understand the heterogeneity of tumor-associated neutrophils (TANs) comprehensively in advanced non-small cell lung cancer (NSCLC) at single-cell resolution is necessary and urgent.Materials and Methods: We applied single-cell RNA-sequencing (scRNA-seq) to portray the subtype-specific transcriptome landscape of TANs in advanced NSCLC using nine freshly obtained specimens. The scRNA-seq data were further processed for pseudo-time analysis to depict the developmental trajectory of TANs. Meanwhile, the interplay between TANs and other cell types within tumor microenvironment (TME) was revealed by intercellular interaction analysis.Results: Seven distinct TAN subtypes were defined, of which, the N3 cluster was considered inflammatory phenotype expressing genes encoding multiple chemotactic cytokines, and correlated with inferior overall survival, indicating that N3 might be a pro-tumorigenic TAN subtype. N1 and N5 clusters were considered to be well differentiated and mature neutrophils based on CXCR2 expression and pseudo-time patterns, and both accounted for relatively high proportions in lung adenocarcinoma. In addition, genes related to neutrophil differentiation were discovered. We also found that TAN subtypes interacted most closely with macrophages through chemokine signaling pathways within TME.Conclusion: Our study refined TAN subtypes and mapped the transcriptome landscape of TANs at single-cell resolution in advanced NSCLC, collectively indicating the heterogeneity of TANs in NSCLC. Neutrophil differentiation-and maturation-related genes were also discovered, which shed light on different functions of TAN subclones in tumor immune escape, and may further provide novel targets for immunotherapy.
引用
收藏
页码:85 / 99
页数:15
相关论文
共 50 条
  • [31] Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer
    Prazanowska, Karolina Hanna
    Hong, Jiwon
    Bin Lim, Su
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (08) : 1816 - 1821
  • [32] M2 tumor-associated macrophages induce tumor progression in non-small cell lung cancer
    Sumitomo, Ryota
    Hirai, Tatsuya
    Huang, Cheng-long
    CANCER SCIENCE, 2021, 112 : 500 - 500
  • [33] Circulating Tumor DNA Genomic and Methylation Profiling in Advanced Non-small Cell Lung Cancer Patients
    Qin, J.
    Shi, D.
    Yin, Y.
    Liu, B.
    Zhai, L.
    Liu, G.
    Wang, L.
    Chen, M.
    Jiang, Y.
    Feng, X.
    Lin, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S74 - S74
  • [34] Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer
    Hu-Lieskovan, Siwen
    Lisberg, Aaron
    Zaretsky, Jesse M.
    Grogan, Tristan R.
    Rizvi, Hira
    Wells, Daniel K.
    Carroll, James
    Cummings, Amy
    Madrigal, John
    Jones, Benjamin
    Gukasyan, Jacklin
    Shintaku, I. Peter
    Slamon, Dennis
    Dubinett, Steven
    Goldman, Jonathan W.
    Elashoff, David
    Hellmann, Matthew D.
    Ribas, Antoni
    Garon, Edward B.
    CLINICAL CANCER RESEARCH, 2019, 25 (16) : 5061 - 5068
  • [35] Immunological profiling for non-small cell lung cancer
    Iwahori, Kota
    Shintani, Yasushi
    Funaki, Soichiro
    Matsumoto, Mitsunobu
    Goto, Kumiko
    Kanazawa, Takayuki
    Okumura, Meinoshin
    Kumanogoh, Atsushi
    Wada, Hisashi
    CANCER SCIENCE, 2018, 109 : 1061 - 1061
  • [36] Using SEREX approach to screen and identify the tumor-associated antigens in non-small cell lung cancer
    Pei, Lu
    Wang, Tingting
    Wang, Peng
    Liu, Hongchun
    Ouyang, Songyun
    Zhang, Jianying
    Dai, Liping
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Molecular profiling of non-small cell lung cancer
    Gibault, L.
    Cazes, A.
    Narjoz, C.
    Blons, H.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2014, 70 (1-2) : 47 - 62
  • [38] Molecular Profiling in Non-Small Cell Lung Cancer
    Raparia, Kirtee
    Villa, Celina
    DeCamp, Malcolm M.
    Patel, Jyoti D.
    Mehta, Minesh P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (04) : 481 - 491
  • [39] Molecular profiling of non-small cell lung cancer
    Forsythe, Marika L.
    Alwithenani, Akram
    Bethune, Drew
    Castonguay, Mathieu
    Drucker, Arik
    Flowerdew, Gordon
    French, Daniel
    Fris, John
    Greer, Wenda
    Henteleff, Harry
    MacNeil, Mary
    Marignani, Paola
    Morzycki, Wojciech
    Plourde, Madeleine
    Snow, Stephanie
    Xu, Zhaolin
    PLOS ONE, 2020, 15 (08):
  • [40] Identification of immune suppressive features in tumor-associated endothelial cells (TECs) in EGFR-mutant non-small cell lung cancer via single-cell RNA sequencing
    Choi, Su-Jin
    Lee, Jii Bum
    Pyo, Kyoung-Ho
    Lee, Gang-Taik
    Park, YoungJoon
    Lee, You Won
    Yun, Mi Ran
    Lim, Kyumin
    Lee, JuHyeon
    Hong, Min Hee
    Lim, Sun Min
    Cho, Byoung Chul
    CANCER RESEARCH, 2024, 84 (06)